Weight-Focused T2D Management

CE / CME

Aligning Real-world Practice to Evidence-Based Care for Weight-Focused T2D Management

Physician Assistants/Physician Associates: 1.00 AAPA Category 1 CME credit

Nurses: 1.00 Nursing contact hour

Physicians: maximum of 1.00 AMA PRA Category 1 Credit

ABIM MOC: maximum of 1.00 Medical Knowledge MOC point

Released: September 10, 2024

Expiration: September 09, 2025

Christina Huynh Nguyen
Christina Huynh Nguyen, MD, DABOM
Lucia M Novak
Lucia M Novak, MSN, ANP-BC, BC-ADM

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

A patient newly diagnosed with T2D presents with an A1C of 8.5% and a history of MI and obesity. The patient has an additional goal of weight loss (current BMI 35 kg/m2). Which of the following is the best option for initial pharmacotherapy for weight loss and reduction of ASCVD risk based on current guidelines?

2.

A patient with a history of T2D presents for routine follow-up. The patient’s A1C is 7.5%, eGFR is 50 mL/min/1.73 m2, and BMI is 29.3 kg/m2. The patient currently is treated with dulaglutide 3 mg weekly. Which of the following would be best for treatment at this time based on clinical evidence and current guidelines?